Non-adherence without borders: Cross continent perspectives and local realities

The importance of medication adherence in cardiovascular disease management is highlighted in this session with the presentation of a health economic study conducted in three middle-income countries: Mexico, Thailand, and China¹.
Prof. Arintaya Phrommintikul highlights the clinical consequences of non-adherence and emphasizes recommendations for better risk factor control. Prof. Nathorn Chaiyakunapruk delves into the study, demonstrating the positive impact of improved adherence, with significant reductions in cardiovascular events and healthcare costs. Dr. Miguel Diaz calls for integrating adherence into health policies and explores innovative technological solutions.

Watch the video to learn more about the perspectives of clinicians, economists, and policymakers on the clinical and economic benefits of improving adherence.

1. Cho JY, et al. Projected Cost Savings with Optimal Medication Adherence in Cardiovascular Disease Patients Requiring Lipid Lowering Therapy: a Multi-National Economic Evaluation Study. JAHA 2024. Manuscript in Press.

Assoc. Prof. Arintaya Phrommintikul

Prof. Nathorn Chaiyakunapruk

Dr. Miguel Angel Díaz Aguilera